Advisor Os, LLC Gilead Sciences, Inc. Transaction History

Advisor Os, LLC

$968 Million
Q3 2024

A detailed history of Advisor Os, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Advisor Os, LLC holds 4,571 shares of GILD stock, worth $417,560. This represents 0.04% of its overall portfolio holdings.

Number of Shares

4,571

Previous 3,899 17.24%

Holding current value

$417,560

Previous $267,000 43.45%

% of portfolio

0.04%

Previous 0.03%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$66.59 - $83.99 $44,748 - $56,441	672 Added 17.24%	4,571 $383,000
Q2 2024 Aug 05, 2024	SELL	$63.15 - $72.88 $4,546 - $5,247	-72 Reduced 1.81%	3,899 $267,000
Q1 2024 May 08, 2024	BUY	$71.58 - $87.29 $17,322 - $21,124	242 Added 6.49%	3,971 $290,000
Q4 2023 Feb 07, 2024	BUY	$73.27 - $83.09 $12,748 - $14,457	174 Added 4.89%	3,729 $302,000
Q3 2023 Nov 02, 2023	SELL	$73.94 - $80.67 $625,976 - $682,952	-8,466 Reduced 70.43%	3,555 $266,000
Q2 2023 Aug 08, 2023	SELL	$76.01 - $86.7 $558,901 - $637,505	-7,353 Reduced 37.95%	12,021 $926,000
Q1 2023 Apr 24, 2023	SELL	$77.31 - $88.08 $46,695 - $53,200	-604 Reduced 3.02%	19,374 $1.61 Million
Q4 2022 Jan 31, 2023	BUY	$62.32 - $89.47 $265,732 - $381,500	4,264 Added 27.14%	19,978 $1.72 Million
Q3 2022 Nov 03, 2022	BUY	$59.54 - $68.01 $66,387 - $75,831	1,115 Added 7.64%	15,714 $970,000
Q2 2022 Aug 02, 2022	BUY	$57.72 - $65.01 $306,550 - $345,268	5,311 Added 57.18%	14,599 $902,000
Q1 2022 May 11, 2022	BUY	$57.92 - $72.58 $158,063 - $198,070	2,729 Added 41.61%	9,288 $552,000
Q4 2021 Feb 04, 2022	BUY	$64.88 - $73.64 $425,547 - $483,004	6,559 New	6,559 $477,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Os, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Os, LLC with notifications on news.

Account